Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now small index

Obesity Recidivism clinical trials

2 of 2 indexed Obesity Recidivism trials are currently recruiting.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Obesity Recidivism: 2 US clinical trials tracked, 2 recruiting.

Obesity Recidivism is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Dr. Christopher McGowan, running 2 of these trials.

Enrollment posture brief

Registry condition obesity-recidivism

OPEN 2 | RECR 100% | LATE 0 | EARLY 0 | RANK #7188 | SPON 2

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Obesity Recidivism (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Obesity Recidivism

Obesity Recidivism lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Obesity Recidivism on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Obesity Recidivism is recruiting above its size-band peers.

    2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Obesity Recidivism records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Gastric Mucosal Ablation (GMA) Device
1 trials
Gastric Fundal Mucosal Ablation (GFMA) Device
1 trials

US sites by state

Facility locations filed on Obesity Recidivism trials. A trial with sites in several states counts in each.

North Carolina 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Obesity Recidivism page

2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Obesity Recidivism condition card totals 2 registered trials; most-linked intervention Gastric Mucosal Ablation (GMA); top US site state North Carolina. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.